Brain

IRB #H-27596/RTOG #R0614: A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy

IRB #H-26359/RTOG #R0627: Phase II Trial of Dasatinib in Patients with Recurrent Glioblastoma Multiforme

Primary teaching affiliate
of BU School of Medicine